Abbott India
ABBOTINDIA · Pharma > Pharmaceuticals & Drugs · Chairman: Munir Shaikh Listing date: Jan. 9, 2010 · Employees: 3585 · Mumbai · http://www.abbott.co.in

Stock Price vs Company Growth
1d
1.1%
1w
4.9%
1m
2.7%
3m
0.7%
6m
2.8%
1y
16.5%
5y
8.8%
10y
20.6%
all
25.0%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 26,630 1.1%
24,620
28,582
Company Overview

Sales
7,004 Cr
Growth: 7.5%
Profit after Tax
1,615 Cr
Growth: 4.0%
Large Cap
56,587 Cr
P/E: 35.1x
Industry P/E: 31.7x
Fundamentals

Sales (Cr) ₹ 7,004
Growth 7.5%
EBITDA 28.1%
P/S 8.1x
Dividend 1.4%
P/E 35.1x
Book Value ₹ 2,448
PEG Ratio 4.7x
ROE 31.7%
P/B 10.9x
Shareholding Pattern

Institutions
Life Insurance Corporation Of India
1.64 %
Promoters
Abbott Capital India Limited
50.44 %
Abbott Healthcare Products Limited
17.62 %
British Colloids Limited
6.92 %
Others
Increase    Decrease    No change
Company Profile Detailed

The company is one of the leading multinational pharmaceutical companies in India and operates with owned manufacturing units and various independent contract/third party manufacturers based across the country. The company sells its products through independent distributors primarily within India.
Investors (50)
Followers (16)